statistiche ricercatore

Continente	#
NA - Nord America	339
EU - Europa	282
AS - Asia	265
SA - Sud America	37
AF - Africa	19
Continente sconosciuto - Info sul continente non disponibili	7
OC - Oceania	1
Totale	950

Nazione	#
US - Stati Uniti d'America	318
RU - Federazione Russa	150
SG - Singapore	110
VN - Vietnam	44
IT - Italia	42
BR - Brasile	28
CN - Cina	27
GB - Regno Unito	26
HK - Hong Kong	22
DE - Germania	16
FR - Francia	14
BD - Bangladesh	13
NL - Olanda	11
CA - Canada	10
KR - Corea	9
PK - Pakistan	7
FI - Finlandia	6
IN - India	6
ID - Indonesia	5
JP - Giappone	5
MX - Messico	5
BJ - Benin	4
NG - Nigeria	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
AR - Argentina	2
EC - Ecuador	2
GT - Guatemala	2
IE - Irlanda	2
MA - Marocco	2
SE - Svezia	2
TG - Togo	2
UA - Ucraina	2
VE - Venezuela	2
AL - Albania	1
AU - Australia	1
BG - Bulgaria	1
CO - Colombia	1
CY - Cipro	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
ES - Italia	1
GH - Ghana	1
GP - Guadalupe	1
HR - Croazia	1
IQ - Iraq	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KH - Cambogia	1
LT - Lituania	1
MY - Malesia	1
PE - Perù	1
PH - Filippine	1
PL - Polonia	1
PR - Porto Rico	1
PY - Paraguay	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TR - Turchia	1
UG - Uganda	1
Totale	943

Nome	#
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY.	264
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study	140
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study	129
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study	114
Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study	104
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis	103
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study	96
Totale	950

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2023/2024	5	0	0	0	0	0	0	0	0	0	0	0	5
2024/2025	97	2	3	2	8	0	3	12	3	7	10	14	33
2025/2026	738	53	77	76	144	145	53	66	33	37	23	25	6
2026/2027	110	16	17	17	60	0	0	0	0	0	0	0	0
Totale													950

CATALOGO DEI PRODOTTI DELLA RICERCA